 Rasika Mathias
Concepts (788)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 89 | 2025 | 1406 | 5.020 |
Why?
| | Polymorphism, Single Nucleotide | 102 | 2025 | 2135 | 4.500 |
Why?
| | Genetic Predisposition to Disease | 70 | 2025 | 2375 | 4.060 |
Why?
| | Asthma | 51 | 2025 | 1920 | 3.500 |
Why?
| | Peanut Hypersensitivity | 6 | 2023 | 147 | 2.940 |
Why?
| | Whole Genome Sequencing | 26 | 2025 | 169 | 2.300 |
Why?
| | Dermatitis, Atopic | 9 | 2023 | 331 | 2.230 |
Why?
| | Precision Medicine | 20 | 2025 | 434 | 2.080 |
Why?
| | Genetic Variation | 30 | 2025 | 1000 | 1.980 |
Why?
| | Food Hypersensitivity | 4 | 2023 | 182 | 1.950 |
Why?
| | Fatty Acid Desaturases | 12 | 2021 | 31 | 1.940 |
Why?
| | Genome, Human | 19 | 2025 | 421 | 1.780 |
Why?
| | Immunoglobulin E | 18 | 2021 | 331 | 1.780 |
Why?
| | Arachis | 5 | 2023 | 112 | 1.780 |
Why?
| | Platelet Aggregation | 12 | 2021 | 112 | 1.710 |
Why?
| | Genotype | 42 | 2025 | 1866 | 1.620 |
Why?
| | Induced Pluripotent Stem Cells | 4 | 2021 | 265 | 1.620 |
Why?
| | Exome | 14 | 2022 | 238 | 1.570 |
Why?
| | Multifactorial Inheritance | 6 | 2025 | 180 | 1.530 |
Why?
| | Genomics | 17 | 2025 | 815 | 1.490 |
Why?
| | Blood Platelets | 12 | 2022 | 437 | 1.430 |
Why?
| | Kaposi Varicelliform Eruption | 4 | 2021 | 21 | 1.380 |
Why?
| | Alleles | 22 | 2023 | 891 | 1.370 |
Why?
| | Genetics, Population | 16 | 2025 | 209 | 1.330 |
Why?
| | Megakaryocytes | 3 | 2021 | 36 | 1.250 |
Why?
| | Phenotype | 51 | 2025 | 3177 | 1.210 |
Why?
| | Quantitative Trait Loci | 18 | 2025 | 364 | 1.170 |
Why?
| | Genetic Loci | 18 | 2021 | 277 | 1.170 |
Why?
| | Fatty Acids, Omega-6 | 5 | 2017 | 48 | 1.140 |
Why?
| | Humans | 244 | 2025 | 141754 | 1.140 |
Why?
| | Nasal Mucosa | 3 | 2025 | 111 | 1.080 |
Why?
| | Multigene Family | 9 | 2021 | 202 | 1.030 |
Why?
| | Coronary Artery Disease | 11 | 2025 | 702 | 1.020 |
Why?
| | DNA Methylation | 7 | 2025 | 648 | 0.980 |
Why?
| | Transcriptome | 5 | 2025 | 1014 | 0.970 |
Why?
| | Receptors, Cell Surface | 8 | 2024 | 398 | 0.970 |
Why?
| | Gene Frequency | 23 | 2024 | 494 | 0.950 |
Why?
| | Gene Expression Regulation | 11 | 2025 | 2608 | 0.930 |
Why?
| | Linoleic Acid | 6 | 2023 | 45 | 0.880 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 12 | 2022 | 99 | 0.870 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2024 | 27 | 0.860 |
Why?
| | Hypersensitivity, Immediate | 2 | 2023 | 43 | 0.820 |
Why?
| | Allergens | 5 | 2023 | 401 | 0.820 |
Why?
| | Immunoglobulin G | 3 | 2022 | 900 | 0.800 |
Why?
| | Genetic Linkage | 14 | 2022 | 288 | 0.790 |
Why?
| | Models, Genetic | 14 | 2025 | 592 | 0.790 |
Why?
| | HLA-DQ alpha-Chains | 2 | 2022 | 16 | 0.770 |
Why?
| | Male | 116 | 2025 | 70179 | 0.760 |
Why?
| | Chromosome Mapping | 16 | 2021 | 504 | 0.750 |
Why?
| | Linkage Disequilibrium | 19 | 2022 | 255 | 0.720 |
Why?
| | 2S Albumins, Plant | 1 | 2022 | 31 | 0.720 |
Why?
| | Female | 116 | 2025 | 75943 | 0.710 |
Why?
| | Gene Expression | 4 | 2025 | 1492 | 0.710 |
Why?
| | Frailty | 4 | 2025 | 177 | 0.710 |
Why?
| | Mosaicism | 4 | 2025 | 74 | 0.710 |
Why?
| | Antigens, Plant | 1 | 2022 | 54 | 0.710 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 11 | 2021 | 1048 | 0.700 |
Why?
| | Nucleotide Transport Proteins | 1 | 2021 | 1 | 0.700 |
Why?
| | High-Throughput Nucleotide Sequencing | 6 | 2019 | 547 | 0.690 |
Why?
| | Middle Aged | 69 | 2025 | 34647 | 0.670 |
Why?
| | von Willebrand Factor | 6 | 2025 | 84 | 0.660 |
Why?
| | Antibody Formation | 1 | 2022 | 298 | 0.660 |
Why?
| | Herpesvirus 1, Human | 1 | 2021 | 81 | 0.640 |
Why?
| | Platelet Function Tests | 3 | 2021 | 34 | 0.640 |
Why?
| | Genetic Association Studies | 13 | 2024 | 375 | 0.630 |
Why?
| | Lung | 10 | 2022 | 4137 | 0.630 |
Why?
| | Lipids | 8 | 2023 | 690 | 0.620 |
Why?
| | Pedigree | 8 | 2025 | 511 | 0.600 |
Why?
| | Adult | 67 | 2025 | 39391 | 0.590 |
Why?
| | Open Reading Frames | 3 | 2021 | 132 | 0.570 |
Why?
| | Fibrinogen | 7 | 2024 | 180 | 0.560 |
Why?
| | Alzheimer Disease | 1 | 2023 | 595 | 0.520 |
Why?
| | Human Migration | 1 | 2016 | 24 | 0.500 |
Why?
| | Chromosomes, Human, Pair 11 | 5 | 2014 | 60 | 0.500 |
Why?
| | Computational Biology | 5 | 2025 | 664 | 0.500 |
Why?
| | Gene-Environment Interaction | 3 | 2014 | 187 | 0.500 |
Why?
| | Risk Factors | 24 | 2025 | 10482 | 0.500 |
Why?
| | Case-Control Studies | 21 | 2025 | 3597 | 0.490 |
Why?
| | Platelet Activation | 4 | 2018 | 95 | 0.490 |
Why?
| | Pulmonary Emphysema | 3 | 2014 | 312 | 0.490 |
Why?
| | Gene Flow | 1 | 2016 | 84 | 0.480 |
Why?
| | Diabetes Mellitus, Type 2 | 10 | 2022 | 2537 | 0.460 |
Why?
| | Evolution, Molecular | 3 | 2019 | 510 | 0.450 |
Why?
| | Software | 5 | 2024 | 678 | 0.450 |
Why?
| | Haplotypes | 14 | 2025 | 499 | 0.450 |
Why?
| | Blood Proteins | 3 | 2025 | 250 | 0.430 |
Why?
| | Geography | 2 | 2016 | 201 | 0.430 |
Why?
| | RNA | 1 | 2021 | 930 | 0.430 |
Why?
| | Aging | 5 | 2025 | 1924 | 0.420 |
Why?
| | Polymorphism, Genetic | 11 | 2017 | 625 | 0.420 |
Why?
| | HLA-B7 Antigen | 1 | 2013 | 7 | 0.420 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2020 | 98 | 0.410 |
Why?
| | Biomarkers | 8 | 2025 | 4190 | 0.410 |
Why?
| | Diet | 4 | 2023 | 1282 | 0.410 |
Why?
| | Bronchial Hyperreactivity | 1 | 2014 | 104 | 0.400 |
Why?
| | Epigenesis, Genetic | 6 | 2024 | 663 | 0.400 |
Why?
| | Quantitative Trait, Heritable | 6 | 2021 | 124 | 0.390 |
Why?
| | Interferon-gamma | 3 | 2015 | 792 | 0.390 |
Why?
| | Hypersensitivity | 4 | 2024 | 260 | 0.370 |
Why?
| | Airway Obstruction | 1 | 2014 | 164 | 0.360 |
Why?
| | Child | 30 | 2025 | 22414 | 0.360 |
Why?
| | Immunity, Cellular | 1 | 2013 | 269 | 0.360 |
Why?
| | Fatty Acids, Omega-3 | 3 | 2021 | 142 | 0.360 |
Why?
| | Mutation | 9 | 2024 | 4015 | 0.350 |
Why?
| | Leukocytes | 4 | 2023 | 309 | 0.350 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2011 | 65 | 0.340 |
Why?
| | Cardiovascular Diseases | 8 | 2025 | 2096 | 0.340 |
Why?
| | Likelihood Functions | 5 | 2012 | 147 | 0.340 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 51 | 0.340 |
Why?
| | Dyslipidemias | 3 | 2016 | 175 | 0.340 |
Why?
| | United States | 29 | 2024 | 15310 | 0.330 |
Why?
| | Liver | 7 | 2024 | 1820 | 0.330 |
Why?
| | Aged | 34 | 2025 | 24746 | 0.320 |
Why?
| | RNA, Long Noncoding | 2 | 2023 | 173 | 0.320 |
Why?
| | DNA, Mitochondrial | 2 | 2023 | 211 | 0.320 |
Why?
| | Cell Adhesion Molecules | 2 | 2024 | 180 | 0.320 |
Why?
| | Genome | 4 | 2022 | 303 | 0.320 |
Why?
| | Factor VIII | 2 | 2024 | 100 | 0.320 |
Why?
| | Diabetes Mellitus | 4 | 2023 | 1077 | 0.310 |
Why?
| | Cohort Studies | 15 | 2021 | 5815 | 0.310 |
Why?
| | Adolescent | 29 | 2023 | 22130 | 0.310 |
Why?
| | Telomere | 5 | 2024 | 279 | 0.310 |
Why?
| | Healthcare Disparities | 3 | 2025 | 673 | 0.300 |
Why?
| | Organ Specificity | 2 | 2021 | 312 | 0.290 |
Why?
| | Computer Simulation | 8 | 2024 | 1015 | 0.290 |
Why?
| | Chromosome Aberrations | 2 | 2024 | 160 | 0.290 |
Why?
| | Pharmacogenetics | 2 | 2020 | 168 | 0.290 |
Why?
| | Genetic Pleiotropy | 3 | 2019 | 31 | 0.280 |
Why?
| | Dietary Fats | 1 | 2010 | 300 | 0.280 |
Why?
| | Smoking | 6 | 2018 | 1603 | 0.280 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 562 | 0.280 |
Why?
| | HLA-DQ beta-Chains | 2 | 2021 | 62 | 0.270 |
Why?
| | Arachidonic Acid | 6 | 2015 | 126 | 0.270 |
Why?
| | Gene Regulatory Networks | 2 | 2024 | 313 | 0.270 |
Why?
| | Atherosclerosis | 2 | 2025 | 404 | 0.270 |
Why?
| | Fasting | 2 | 2022 | 284 | 0.260 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 918 | 0.260 |
Why?
| | Body Height | 4 | 2015 | 200 | 0.260 |
Why?
| | Loss of Function Mutation | 3 | 2021 | 46 | 0.250 |
Why?
| | Restless Legs Syndrome | 1 | 2006 | 21 | 0.250 |
Why?
| | Aspirin | 4 | 2018 | 385 | 0.250 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2006 | 20 | 0.250 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2006 | 68 | 0.240 |
Why?
| | Computer Graphics | 1 | 2006 | 42 | 0.240 |
Why?
| | Schistosoma japonicum | 2 | 2017 | 31 | 0.240 |
Why?
| | Biological Specimen Banks | 3 | 2024 | 99 | 0.240 |
Why?
| | Lipoprotein Lipase | 1 | 2006 | 56 | 0.240 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2017 | 761 | 0.240 |
Why?
| | Health Status Disparities | 3 | 2025 | 298 | 0.230 |
Why?
| | Hematopoietic Stem Cells | 3 | 2024 | 411 | 0.230 |
Why?
| | Helminthiasis | 2 | 2017 | 11 | 0.230 |
Why?
| | Serine | 1 | 2006 | 148 | 0.230 |
Why?
| | Endophenotypes | 1 | 2025 | 21 | 0.230 |
Why?
| | von Willebrand Diseases | 1 | 2025 | 28 | 0.230 |
Why?
| | Genomic Structural Variation | 1 | 2025 | 12 | 0.230 |
Why?
| | Hematopoiesis | 2 | 2023 | 194 | 0.230 |
Why?
| | Chromosomes, Human, Y | 1 | 2025 | 26 | 0.230 |
Why?
| | Membrane Proteins | 7 | 2017 | 1158 | 0.230 |
Why?
| | Models, Statistical | 7 | 2021 | 671 | 0.220 |
Why?
| | Cholesterol, HDL | 4 | 2016 | 196 | 0.220 |
Why?
| | Germ-Line Mutation | 2 | 2023 | 168 | 0.220 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2025 | 33 | 0.220 |
Why?
| | Consanguinity | 2 | 2005 | 49 | 0.220 |
Why?
| | Chromosome Deletion | 1 | 2025 | 118 | 0.220 |
Why?
| | Kininogens | 1 | 2024 | 6 | 0.220 |
Why?
| | Inflammation | 6 | 2024 | 2902 | 0.220 |
Why?
| | Chromosomes, Human, Pair 16 | 3 | 2021 | 36 | 0.210 |
Why?
| | Young Adult | 13 | 2022 | 13749 | 0.210 |
Why?
| | Lectins, C-Type | 1 | 2024 | 63 | 0.210 |
Why?
| | Telomere Homeostasis | 1 | 2024 | 35 | 0.210 |
Why?
| | Interleukin-13 | 3 | 2023 | 149 | 0.210 |
Why?
| | Blood Pressure | 6 | 2022 | 1748 | 0.210 |
Why?
| | Chemokines, CC | 2 | 2014 | 34 | 0.210 |
Why?
| | Forced Expiratory Volume | 4 | 2019 | 484 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 2 | 2014 | 2765 | 0.210 |
Why?
| | Liver Cirrhosis | 2 | 2017 | 282 | 0.210 |
Why?
| | Population Groups | 3 | 2019 | 58 | 0.200 |
Why?
| | Fibronectins | 1 | 2024 | 136 | 0.200 |
Why?
| | Menopause, Premature | 1 | 2023 | 12 | 0.200 |
Why?
| | Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 2 | 2022 | 3 | 0.200 |
Why?
| | Barbados | 8 | 2013 | 8 | 0.200 |
Why?
| | Erythrocytes | 2 | 2021 | 707 | 0.200 |
Why?
| | Respiration | 2 | 2014 | 210 | 0.200 |
Why?
| | Proteomics | 3 | 2024 | 1138 | 0.200 |
Why?
| | Blood Cells | 1 | 2022 | 39 | 0.200 |
Why?
| | Metabolic Syndrome | 3 | 2011 | 349 | 0.200 |
Why?
| | Frameshift Mutation | 1 | 2022 | 32 | 0.190 |
Why?
| | Interleukin-4 | 2 | 2023 | 215 | 0.190 |
Why?
| | Chromosomes, Human, X | 2 | 2021 | 77 | 0.190 |
Why?
| | Promoter Regions, Genetic | 6 | 2023 | 1243 | 0.190 |
Why?
| | Telomere Shortening | 1 | 2022 | 19 | 0.190 |
Why?
| | Proteome | 2 | 2024 | 485 | 0.190 |
Why?
| | Eczema | 1 | 2023 | 70 | 0.190 |
Why?
| | Acute Coronary Syndrome | 2 | 2016 | 283 | 0.180 |
Why?
| | Genetic Heterogeneity | 3 | 2016 | 58 | 0.180 |
Why?
| | Desensitization, Immunologic | 1 | 2023 | 95 | 0.180 |
Why?
| | Coronary Disease | 2 | 2019 | 371 | 0.180 |
Why?
| | Gastritis | 1 | 2023 | 118 | 0.180 |
Why?
| | Nerve Tissue Proteins | 5 | 2022 | 605 | 0.180 |
Why?
| | Enteritis | 1 | 2023 | 107 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2025 | 1115 | 0.180 |
Why?
| | HLA-A2 Antigen | 1 | 2021 | 49 | 0.180 |
Why?
| | Pseudomonas Infections | 2 | 2015 | 230 | 0.180 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.180 |
Why?
| | Americas | 1 | 2021 | 28 | 0.170 |
Why?
| | DNA Copy Number Variations | 2 | 2020 | 177 | 0.170 |
Why?
| | Spain | 1 | 2021 | 46 | 0.170 |
Why?
| | Cyclooxygenase Inhibitors | 2 | 2014 | 83 | 0.170 |
Why?
| | Patient Compliance | 1 | 2025 | 611 | 0.170 |
Why?
| | Peru | 1 | 2021 | 61 | 0.170 |
Why?
| | Leishmaniasis, Visceral | 1 | 2001 | 22 | 0.170 |
Why?
| | Gene Ontology | 1 | 2021 | 53 | 0.170 |
Why?
| | Pulmonary Medicine | 2 | 2019 | 83 | 0.170 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2021 | 89 | 0.170 |
Why?
| | Odds Ratio | 7 | 2019 | 1057 | 0.170 |
Why?
| | Glutathione Transferase | 1 | 2021 | 101 | 0.170 |
Why?
| | Social Determinants of Health | 1 | 2025 | 274 | 0.170 |
Why?
| | Cytokines | 4 | 2023 | 2100 | 0.170 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1485 | 0.170 |
Why?
| | Risk | 7 | 2019 | 907 | 0.170 |
Why?
| | gamma-Linolenic Acid | 1 | 2020 | 2 | 0.170 |
Why?
| | Chromosomes, Human, Pair 19 | 3 | 2012 | 28 | 0.160 |
Why?
| | Algorithms | 7 | 2025 | 1768 | 0.160 |
Why?
| | Lipid Metabolism | 2 | 2021 | 528 | 0.160 |
Why?
| | Immunologic Factors | 1 | 2022 | 249 | 0.160 |
Why?
| | Receptors, Nicotinic | 2 | 2013 | 344 | 0.160 |
Why?
| | HLA-DQ Antigens | 1 | 2021 | 178 | 0.160 |
Why?
| | Soybean Oil | 1 | 2020 | 15 | 0.160 |
Why?
| | Plant Oils | 1 | 2020 | 32 | 0.160 |
Why?
| | Amish | 1 | 2020 | 7 | 0.160 |
Why?
| | Energy Intake | 1 | 2023 | 513 | 0.160 |
Why?
| | beta-Globins | 1 | 2019 | 8 | 0.160 |
Why?
| | Base Sequence | 4 | 2021 | 2180 | 0.160 |
Why?
| | Hemorrhage | 1 | 2025 | 760 | 0.160 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2018 | 475 | 0.160 |
Why?
| | Genomic Instability | 1 | 2020 | 58 | 0.160 |
Why?
| | Occipital Lobe | 1 | 2019 | 26 | 0.150 |
Why?
| | Thrombosis | 5 | 2024 | 399 | 0.150 |
Why?
| | Cholesterol, LDL | 5 | 2022 | 361 | 0.150 |
Why?
| | Homozygote | 3 | 2016 | 201 | 0.150 |
Why?
| | 8,11,14-Eicosatrienoic Acid | 3 | 2020 | 6 | 0.150 |
Why?
| | Mutation, Missense | 2 | 2023 | 340 | 0.150 |
Why?
| | Diabetic Nephropathies | 1 | 2023 | 299 | 0.150 |
Why?
| | HLA-DRB1 Chains | 1 | 2020 | 112 | 0.150 |
Why?
| | Tissue Plasminogen Activator | 1 | 2021 | 239 | 0.150 |
Why?
| | Chromosomes, Human, Pair 12 | 4 | 2019 | 20 | 0.150 |
Why?
| | Eicosanoids | 2 | 2022 | 63 | 0.150 |
Why?
| | Photometry | 1 | 2019 | 4 | 0.150 |
Why?
| | Parietal Lobe | 1 | 2019 | 60 | 0.150 |
Why?
| | Th2 Cells | 4 | 2023 | 177 | 0.150 |
Why?
| | Genes, Mitochondrial | 1 | 2018 | 13 | 0.150 |
Why?
| | Sleep Medicine Specialty | 1 | 2019 | 11 | 0.150 |
Why?
| | Chromatography, Gas | 1 | 2019 | 33 | 0.150 |
Why?
| | Plasticizers | 1 | 2019 | 16 | 0.150 |
Why?
| | Flame Retardants | 1 | 2019 | 11 | 0.150 |
Why?
| | Aged, 80 and over | 10 | 2025 | 7923 | 0.150 |
Why?
| | Chromosomes, Human, Pair 6 | 2 | 2025 | 47 | 0.150 |
Why?
| | Brazil | 6 | 2017 | 173 | 0.150 |
Why?
| | Clinical Trials as Topic | 2 | 2022 | 1057 | 0.150 |
Why?
| | Receptors, Immunologic | 3 | 2022 | 215 | 0.150 |
Why?
| | Temporal Lobe | 1 | 2019 | 105 | 0.150 |
Why?
| | Metabolomics | 2 | 2024 | 704 | 0.150 |
Why?
| | India | 3 | 2009 | 208 | 0.150 |
Why?
| | Metabolism | 1 | 2018 | 44 | 0.150 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2018 | 8 | 0.150 |
Why?
| | Brain | 2 | 2023 | 2868 | 0.150 |
Why?
| | Databases, Genetic | 4 | 2021 | 243 | 0.150 |
Why?
| | Smad2 Protein | 1 | 2018 | 39 | 0.140 |
Why?
| | Family | 4 | 2012 | 680 | 0.140 |
Why?
| | Eosinophilic Esophagitis | 1 | 2023 | 329 | 0.140 |
Why?
| | Sex Characteristics | 3 | 2014 | 792 | 0.140 |
Why?
| | Computer Communication Networks | 1 | 2018 | 33 | 0.140 |
Why?
| | Hominidae | 1 | 2019 | 88 | 0.140 |
Why?
| | Exons | 3 | 2016 | 353 | 0.140 |
Why?
| | Indians, North American | 2 | 2021 | 655 | 0.140 |
Why?
| | Frontal Lobe | 1 | 2019 | 163 | 0.140 |
Why?
| | Blood Glucose | 4 | 2021 | 2278 | 0.140 |
Why?
| | Telomerase | 2 | 2024 | 247 | 0.140 |
Why?
| | Child, Preschool | 16 | 2021 | 11512 | 0.140 |
Why?
| | Lipopolysaccharide Receptors | 2 | 2010 | 91 | 0.140 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2017 | 34 | 0.140 |
Why?
| | Immunotherapy | 1 | 2022 | 646 | 0.140 |
Why?
| | Comorbidity | 1 | 2023 | 1664 | 0.140 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 420 | 0.140 |
Why?
| | Africa | 2 | 2020 | 119 | 0.130 |
Why?
| | Organophosphates | 1 | 2019 | 174 | 0.130 |
Why?
| | Noncommunicable Diseases | 1 | 2017 | 19 | 0.130 |
Why?
| | Quality Control | 4 | 2021 | 171 | 0.130 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2017 | 8 | 0.130 |
Why?
| | Information Storage and Retrieval | 1 | 2018 | 120 | 0.130 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2017 | 92 | 0.130 |
Why?
| | Molecular Epidemiology | 3 | 2013 | 72 | 0.130 |
Why?
| | Rural Health | 1 | 1997 | 83 | 0.130 |
Why?
| | Schistosoma mansoni | 1 | 2017 | 43 | 0.130 |
Why?
| | Endemic Diseases | 1 | 2017 | 36 | 0.130 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 752 | 0.130 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2017 | 25 | 0.130 |
Why?
| | Animals | 19 | 2023 | 37749 | 0.130 |
Why?
| | Scavenger Receptors, Class B | 1 | 2016 | 14 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2020 | 531 | 0.130 |
Why?
| | Sequence Analysis, DNA | 6 | 2018 | 825 | 0.130 |
Why?
| | Cyclooxygenase 1 | 2 | 2014 | 28 | 0.130 |
Why?
| | DNA, Intergenic | 1 | 2016 | 29 | 0.130 |
Why?
| | Carotid Artery Diseases | 1 | 2016 | 62 | 0.130 |
Why?
| | Schistosomiasis | 1 | 2017 | 50 | 0.130 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 623 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 189 | 0.120 |
Why?
| | White Matter | 1 | 2018 | 148 | 0.120 |
Why?
| | Adrenal Cortex Hormones | 1 | 2019 | 501 | 0.120 |
Why?
| | Erythropoiesis | 1 | 2016 | 56 | 0.120 |
Why?
| | Myocardial Infarction | 2 | 2020 | 1069 | 0.120 |
Why?
| | Immune System Diseases | 1 | 2016 | 40 | 0.120 |
Why?
| | Mitochondrial Proteins | 1 | 2018 | 261 | 0.120 |
Why?
| | Kidney Transplantation | 2 | 2012 | 678 | 0.120 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2017 | 171 | 0.120 |
Why?
| | Lipoprotein(a) | 1 | 2016 | 68 | 0.120 |
Why?
| | Decision Support Systems, Clinical | 1 | 2020 | 263 | 0.120 |
Why?
| | Sexism | 1 | 2016 | 68 | 0.120 |
Why?
| | Anthropometry | 2 | 2022 | 208 | 0.120 |
Why?
| | Cell Differentiation | 2 | 2021 | 2006 | 0.120 |
Why?
| | Lung Diseases, Interstitial | 1 | 2022 | 654 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 574 | 0.120 |
Why?
| | Genes, Modifier | 1 | 2015 | 2 | 0.120 |
Why?
| | Caveolin 2 | 1 | 2015 | 3 | 0.120 |
Why?
| | CpG Islands | 3 | 2023 | 165 | 0.120 |
Why?
| | Factor VII | 1 | 2015 | 25 | 0.120 |
Why?
| | Molecular Sequence Annotation | 3 | 2021 | 95 | 0.120 |
Why?
| | Receptors, Interferon | 1 | 2015 | 52 | 0.120 |
Why?
| | United Kingdom | 3 | 2021 | 322 | 0.120 |
Why?
| | Respiratory Tract Diseases | 1 | 2017 | 181 | 0.120 |
Why?
| | Collagen | 2 | 2015 | 460 | 0.110 |
Why?
| | Schistosomiasis japonica | 1 | 2015 | 32 | 0.110 |
Why?
| | Mutation Rate | 1 | 2015 | 29 | 0.110 |
Why?
| | Minority Groups | 1 | 2017 | 278 | 0.110 |
Why?
| | Interleukin-10 | 2 | 2017 | 310 | 0.110 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 159 | 0.110 |
Why?
| | Scleroderma, Systemic | 1 | 2016 | 122 | 0.110 |
Why?
| | Menopause | 2 | 2023 | 320 | 0.110 |
Why?
| | Mutant Chimeric Proteins | 1 | 2014 | 6 | 0.110 |
Why?
| | KCNQ1 Potassium Channel | 1 | 2014 | 8 | 0.110 |
Why?
| | Machine Learning | 3 | 2025 | 556 | 0.110 |
Why?
| | HMGA2 Protein | 1 | 2014 | 8 | 0.110 |
Why?
| | HLA-B27 Antigen | 1 | 2014 | 17 | 0.110 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2903 | 0.110 |
Why?
| | Chromosome Disorders | 1 | 2014 | 43 | 0.110 |
Why?
| | Cross-Sectional Studies | 6 | 2024 | 5697 | 0.110 |
Why?
| | Transcription Factor 7-Like 2 Protein | 1 | 2014 | 26 | 0.110 |
Why?
| | Hypertension | 2 | 2022 | 1254 | 0.110 |
Why?
| | Rhinitis, Allergic | 1 | 2014 | 42 | 0.100 |
Why?
| | Family Health | 4 | 2011 | 194 | 0.100 |
Why?
| | Exercise | 1 | 2025 | 2112 | 0.100 |
Why?
| | Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 4 | 0.100 |
Why?
| | Cystic Fibrosis | 2 | 2015 | 1130 | 0.100 |
Why?
| | Obesity | 2 | 2022 | 3008 | 0.100 |
Why?
| | beta-Defensins | 1 | 2013 | 23 | 0.100 |
Why?
| | Body Mass Index | 5 | 2022 | 2385 | 0.100 |
Why?
| | Tobacco Use Disorder | 2 | 2013 | 245 | 0.100 |
Why?
| | Pseudomonas aeruginosa | 2 | 2015 | 358 | 0.100 |
Why?
| | Vital Capacity | 1 | 2014 | 306 | 0.100 |
Why?
| | Stroke | 1 | 2022 | 1158 | 0.100 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 1993 | 14 | 0.100 |
Why?
| | Kv Channel-Interacting Proteins | 1 | 2013 | 2 | 0.100 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 84 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 570 | 0.100 |
Why?
| | Longitudinal Studies | 5 | 2021 | 2938 | 0.100 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2011 | 75 | 0.100 |
Why?
| | Professional Impairment | 1 | 1993 | 3 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2021 | 4212 | 0.100 |
Why?
| | Virginia | 2 | 2005 | 64 | 0.100 |
Why?
| | Family Practice | 1 | 1997 | 464 | 0.100 |
Why?
| | Critical Care | 1 | 2019 | 650 | 0.100 |
Why?
| | Dentists | 1 | 1993 | 21 | 0.100 |
Why?
| | Genetic Markers | 5 | 2016 | 343 | 0.100 |
Why?
| | HEK293 Cells | 3 | 2021 | 737 | 0.100 |
Why?
| | Skin Tests | 4 | 2017 | 97 | 0.100 |
Why?
| | K562 Cells | 2 | 2024 | 95 | 0.100 |
Why?
| | Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 8 | 0.100 |
Why?
| | Principal Component Analysis | 2 | 2010 | 198 | 0.100 |
Why?
| | Ankyrins | 1 | 2012 | 12 | 0.100 |
Why?
| | Kallikreins | 1 | 2012 | 27 | 0.100 |
Why?
| | Duffy Blood-Group System | 2 | 2011 | 5 | 0.100 |
Why?
| | Nuclear Proteins | 1 | 2017 | 719 | 0.100 |
Why?
| | Parents | 3 | 2007 | 1440 | 0.100 |
Why?
| | Fatty Acids | 1 | 2015 | 450 | 0.090 |
Why?
| | Education, Medical, Graduate | 1 | 1997 | 526 | 0.090 |
Why?
| | Microbiota | 1 | 2020 | 768 | 0.090 |
Why?
| | Triglycerides | 3 | 2015 | 514 | 0.090 |
Why?
| | Hepatitis B | 1 | 1993 | 69 | 0.090 |
Why?
| | Respiratory Sounds | 1 | 2012 | 109 | 0.090 |
Why?
| | Leukocyte Count | 2 | 2011 | 328 | 0.090 |
Why?
| | Mitochondria | 1 | 2018 | 979 | 0.090 |
Why?
| | Phylogeny | 1 | 2016 | 1019 | 0.090 |
Why?
| | Dioxygenases | 2 | 2023 | 33 | 0.090 |
Why?
| | Prostate-Specific Antigen | 1 | 2012 | 166 | 0.090 |
Why?
| | Steroids | 1 | 2012 | 163 | 0.090 |
Why?
| | Heterozygote | 3 | 2021 | 308 | 0.090 |
Why?
| | Insulin | 4 | 2022 | 2491 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 16 | 0.090 |
Why?
| | Patients | 1 | 1993 | 180 | 0.090 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2011 | 39 | 0.090 |
Why?
| | Aquaporin 5 | 1 | 2010 | 3 | 0.090 |
Why?
| | Microtubule-Associated Proteins | 1 | 2012 | 198 | 0.090 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3356 | 0.090 |
Why?
| | Infant | 9 | 2021 | 9843 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1771 | 0.080 |
Why?
| | Disease Progression | 5 | 2019 | 2800 | 0.080 |
Why?
| | Chromosomes | 1 | 2011 | 105 | 0.080 |
Why?
| | Heredity | 2 | 2021 | 11 | 0.080 |
Why?
| | Cockroaches | 1 | 2010 | 22 | 0.080 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2010 | 29 | 0.080 |
Why?
| | Curriculum | 1 | 1997 | 1039 | 0.080 |
Why?
| | Death Domain Receptor Signaling Adaptor Proteins | 1 | 2009 | 2 | 0.080 |
Why?
| | Recombination, Genetic | 1 | 2011 | 206 | 0.080 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2010 | 37 | 0.080 |
Why?
| | Mice | 10 | 2023 | 18109 | 0.080 |
Why?
| | Eosinophils | 2 | 2025 | 326 | 0.080 |
Why?
| | Incidence | 4 | 2019 | 2806 | 0.080 |
Why?
| | Lectins | 1 | 2010 | 46 | 0.080 |
Why?
| | Interviews as Topic | 2 | 2006 | 854 | 0.080 |
Why?
| | Myocardial Ischemia | 1 | 2011 | 280 | 0.080 |
Why?
| | Nuclear Family | 2 | 2007 | 57 | 0.080 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2009 | 66 | 0.080 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 9 | 0.080 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2009 | 78 | 0.080 |
Why?
| | Isoenzymes | 1 | 2010 | 302 | 0.080 |
Why?
| | Chromosomes, Human | 1 | 2009 | 44 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3737 | 0.080 |
Why?
| | Arginine | 1 | 2010 | 260 | 0.080 |
Why?
| | Tryptophan | 1 | 2010 | 188 | 0.080 |
Why?
| | Caribbean Region | 4 | 2011 | 29 | 0.080 |
Why?
| | Receptors, Leptin | 1 | 2009 | 25 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 196 | 0.080 |
Why?
| | Confidence Intervals | 2 | 2014 | 329 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2017 | 1027 | 0.070 |
Why?
| | Graft Rejection | 1 | 2012 | 547 | 0.070 |
Why?
| | Renal Dialysis | 1 | 1993 | 457 | 0.070 |
Why?
| | Agammaglobulinemia | 1 | 1989 | 36 | 0.070 |
Why?
| | Nephrotic Syndrome | 1 | 1989 | 39 | 0.070 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2009 | 57 | 0.070 |
Why?
| | Regression Analysis | 3 | 2025 | 1023 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2022 | 389 | 0.070 |
Why?
| | Genotyping Techniques | 2 | 2019 | 73 | 0.070 |
Why?
| | Proto-Oncogene Proteins | 2 | 2023 | 624 | 0.070 |
Why?
| | Proteoglycans | 1 | 2009 | 109 | 0.070 |
Why?
| | Thromboxane B2 | 3 | 2018 | 27 | 0.070 |
Why?
| | Cholesterol | 2 | 2015 | 405 | 0.070 |
Why?
| | Siblings | 2 | 2011 | 216 | 0.070 |
Why?
| | Alcoholism | 3 | 2005 | 823 | 0.070 |
Why?
| | Chromosomes, Human, Pair 17 | 3 | 2019 | 55 | 0.070 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1056 | 0.070 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2007 | 20 | 0.070 |
Why?
| | Research Design | 2 | 2019 | 1146 | 0.070 |
Why?
| | British Columbia | 3 | 1997 | 22 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 855 | 0.070 |
Why?
| | Cognition | 1 | 2015 | 1228 | 0.060 |
Why?
| | Age of Onset | 3 | 2013 | 534 | 0.060 |
Why?
| | Antigens, CD | 1 | 2010 | 545 | 0.060 |
Why?
| | Inheritance Patterns | 1 | 2006 | 44 | 0.060 |
Why?
| | Databases, Factual | 1 | 2012 | 1448 | 0.060 |
Why?
| | Thrombophilia | 1 | 2007 | 90 | 0.060 |
Why?
| | Infant, Newborn | 6 | 2012 | 6289 | 0.060 |
Why?
| | Deoxyribonuclease HindIII | 1 | 2006 | 2 | 0.060 |
Why?
| | alpha-Linolenic Acid | 2 | 2017 | 8 | 0.060 |
Why?
| | Registries | 1 | 2014 | 2144 | 0.060 |
Why?
| | Europe | 2 | 2020 | 411 | 0.060 |
Why?
| | Adenosine Diphosphate | 2 | 2017 | 82 | 0.060 |
Why?
| | Meta-Analysis as Topic | 3 | 2012 | 185 | 0.060 |
Why?
| | Neoplasm Proteins | 2 | 2022 | 434 | 0.060 |
Why?
| | Chromosomes, Human, Pair 4 | 2 | 2019 | 32 | 0.060 |
Why?
| | Platelet Count | 2 | 2016 | 89 | 0.060 |
Why?
| | Prospective Studies | 5 | 2020 | 7777 | 0.060 |
Why?
| | DNA Mutational Analysis | 2 | 2020 | 398 | 0.060 |
Why?
| | Epinephrine | 2 | 2017 | 148 | 0.060 |
Why?
| | Glucose | 2 | 2022 | 1041 | 0.060 |
Why?
| | Transfection | 3 | 2016 | 943 | 0.060 |
Why?
| | ABO Blood-Group System | 1 | 2025 | 53 | 0.060 |
Why?
| | Complement C3 | 1 | 2006 | 203 | 0.060 |
Why?
| | Receptors, Prostaglandin | 1 | 2004 | 22 | 0.060 |
Why?
| | Mucins | 1 | 2005 | 75 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2005 | 168 | 0.050 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2024 | 28 | 0.050 |
Why?
| | Janus Kinase 2 | 1 | 2024 | 32 | 0.050 |
Why?
| | Mites | 1 | 2004 | 8 | 0.050 |
Why?
| | Loss of Heterozygosity | 1 | 2024 | 51 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 25 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1942 | 0.050 |
Why?
| | Gene Targeting | 2 | 2020 | 83 | 0.050 |
Why?
| | Kidney | 2 | 2023 | 1482 | 0.050 |
Why?
| | Eye Proteins | 2 | 2021 | 93 | 0.050 |
Why?
| | Matched-Pair Analysis | 1 | 2003 | 38 | 0.050 |
Why?
| | Chromosomes, Human, Pair 14 | 2 | 2014 | 21 | 0.050 |
Why?
| | Adult Children | 1 | 2003 | 26 | 0.050 |
Why?
| | Receptors, Complement | 1 | 2004 | 122 | 0.050 |
Why?
| | Time | 1 | 2003 | 87 | 0.050 |
Why?
| | Epigenomics | 1 | 2024 | 114 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4421 | 0.050 |
Why?
| | Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 2 | 0.050 |
Why?
| | Societies, Medical | 2 | 2019 | 859 | 0.050 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2024 | 108 | 0.050 |
Why?
| | Genes | 1 | 2003 | 229 | 0.050 |
Why?
| | Diabetic Retinopathy | 1 | 2006 | 201 | 0.050 |
Why?
| | Sex Factors | 3 | 2014 | 2063 | 0.050 |
Why?
| | Sulfites | 1 | 2023 | 9 | 0.050 |
Why?
| | Point Mutation | 1 | 2004 | 237 | 0.050 |
Why?
| | Aminopeptidases | 1 | 2023 | 22 | 0.050 |
Why?
| | Eosinophilia | 2 | 2023 | 226 | 0.050 |
Why?
| | Environment | 2 | 2010 | 342 | 0.050 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 502 | 0.050 |
Why?
| | Genes, Reporter | 2 | 2015 | 274 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2024 | 152 | 0.050 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2022 | 15 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2016 | 2828 | 0.050 |
Why?
| | Cell Line | 3 | 2015 | 2887 | 0.050 |
Why?
| | Pruritus | 1 | 2023 | 64 | 0.050 |
Why?
| | Cooperative Behavior | 1 | 2005 | 463 | 0.050 |
Why?
| | Syndrome | 1 | 2023 | 378 | 0.050 |
Why?
| | Electroencephalography | 1 | 2005 | 524 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 133 | 0.050 |
Why?
| | Fruit | 1 | 2023 | 147 | 0.050 |
Why?
| | Vegetables | 1 | 2023 | 161 | 0.050 |
Why?
| | Risk Assessment | 2 | 2025 | 3508 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4629 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2023 | 280 | 0.040 |
Why?
| | Age Factors | 3 | 2003 | 3294 | 0.040 |
Why?
| | RGS Proteins | 1 | 2021 | 17 | 0.040 |
Why?
| | Internationality | 2 | 2013 | 158 | 0.040 |
Why?
| | Postmenopause | 1 | 2023 | 371 | 0.040 |
Why?
| | Subcutaneous Tissue | 1 | 2021 | 25 | 0.040 |
Why?
| | INDEL Mutation | 1 | 2021 | 17 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2001 | 28 | 0.040 |
Why?
| | Colombia | 2 | 2013 | 41 | 0.040 |
Why?
| | Antibodies, Protozoan | 1 | 2001 | 39 | 0.040 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2021 | 32 | 0.040 |
Why?
| | alpha Karyopherins | 1 | 2020 | 11 | 0.040 |
Why?
| | Receptors, LDL | 1 | 2020 | 52 | 0.040 |
Why?
| | Antibodies, Heterophile | 1 | 2000 | 13 | 0.040 |
Why?
| | Lymphocytosis | 1 | 2000 | 11 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2021 | 93 | 0.040 |
Why?
| | Cricetinae | 1 | 2001 | 301 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2021 | 125 | 0.040 |
Why?
| | Sepsis | 1 | 2007 | 621 | 0.040 |
Why?
| | Tripartite Motif Proteins | 1 | 2020 | 41 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2021 | 153 | 0.040 |
Why?
| | Population Density | 1 | 2021 | 97 | 0.040 |
Why?
| | Prognosis | 2 | 2021 | 4080 | 0.040 |
Why?
| | Lod Score | 3 | 2009 | 64 | 0.040 |
Why?
| | Sample Size | 1 | 2021 | 128 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2021 | 84 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2020 | 54 | 0.040 |
Why?
| | Names | 1 | 2000 | 14 | 0.040 |
Why?
| | Eating | 1 | 2023 | 392 | 0.040 |
Why?
| | Gene Editing | 1 | 2021 | 86 | 0.040 |
Why?
| | Mutagenesis | 1 | 2021 | 182 | 0.040 |
Why?
| | Lens, Crystalline | 1 | 2001 | 133 | 0.040 |
Why?
| | Respiratory Function Tests | 2 | 2013 | 560 | 0.040 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2020 | 26 | 0.040 |
Why?
| | Mucin-5B | 1 | 2022 | 222 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 792 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2006 | 852 | 0.040 |
Why?
| | Gene Silencing | 1 | 2020 | 197 | 0.040 |
Why?
| | A549 Cells | 1 | 2019 | 74 | 0.040 |
Why?
| | Emigration and Immigration | 1 | 2000 | 56 | 0.040 |
Why?
| | North America | 2 | 2011 | 307 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2023 | 430 | 0.040 |
Why?
| | Fibrinolysis | 1 | 2021 | 161 | 0.040 |
Why?
| | Siberia | 1 | 2019 | 9 | 0.040 |
Why?
| | Body Weight | 1 | 2003 | 997 | 0.040 |
Why?
| | Information Dissemination | 1 | 2021 | 224 | 0.040 |
Why?
| | Recombinases | 1 | 2019 | 6 | 0.040 |
Why?
| | Flame Ionization | 1 | 2019 | 2 | 0.040 |
Why?
| | Cloud Computing | 1 | 2019 | 7 | 0.040 |
Why?
| | Event-Related Potentials, P300 | 1 | 1999 | 15 | 0.040 |
Why?
| | Waist-Hip Ratio | 1 | 2018 | 35 | 0.040 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2019 | 34 | 0.040 |
Why?
| | Linear Models | 2 | 2017 | 858 | 0.040 |
Why?
| | Monoamine Oxidase | 1 | 1999 | 28 | 0.040 |
Why?
| | Cataract | 1 | 2001 | 223 | 0.040 |
Why?
| | Proportional Hazards Models | 2 | 2014 | 1268 | 0.040 |
Why?
| | Antibodies, Viral | 2 | 2000 | 656 | 0.040 |
Why?
| | Limit of Detection | 1 | 2019 | 94 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 57 | 0.040 |
Why?
| | Prevalence | 2 | 2016 | 2799 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 632 | 0.040 |
Why?
| | Calibration | 1 | 2019 | 152 | 0.040 |
Why?
| | Reference Standards | 1 | 2019 | 186 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2024 | 816 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2018 | 10 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 481 | 0.040 |
Why?
| | Disease Susceptibility | 2 | 2014 | 353 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2019 | 594 | 0.030 |
Why?
| | Virus Diseases | 1 | 2000 | 215 | 0.030 |
Why?
| | Double-Blind Method | 2 | 2020 | 1989 | 0.030 |
Why?
| | Skin | 1 | 2023 | 765 | 0.030 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2017 | 27 | 0.030 |
Why?
| | Histone Code | 1 | 2017 | 33 | 0.030 |
Why?
| | HIV Infections | 1 | 1993 | 3022 | 0.030 |
Why?
| | Rubella Vaccine | 1 | 1997 | 6 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 467 | 0.030 |
Why?
| | Apolipoprotein E2 | 1 | 2016 | 3 | 0.030 |
Why?
| | Program Evaluation | 1 | 2021 | 930 | 0.030 |
Why?
| | Apolipoprotein B-100 | 1 | 2016 | 13 | 0.030 |
Why?
| | Selection, Genetic | 1 | 2019 | 264 | 0.030 |
Why?
| | Rubella | 1 | 1997 | 23 | 0.030 |
Why?
| | Adipocytes | 1 | 2018 | 227 | 0.030 |
Why?
| | Preceptorship | 1 | 1997 | 68 | 0.030 |
Why?
| | GPI-Linked Proteins | 1 | 2017 | 78 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2019 | 232 | 0.030 |
Why?
| | Interleukin-33 | 1 | 2017 | 50 | 0.030 |
Why?
| | Workflow | 1 | 2018 | 175 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6966 | 0.030 |
Why?
| | Denmark | 1 | 2016 | 47 | 0.030 |
Why?
| | Data Accuracy | 1 | 2017 | 65 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2747 | 0.030 |
Why?
| | Mean Platelet Volume | 1 | 2016 | 3 | 0.030 |
Why?
| | Demography | 1 | 2017 | 296 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2018 | 521 | 0.030 |
Why?
| | Allelic Imbalance | 1 | 2016 | 9 | 0.030 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2016 | 68 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 2016 | 30 | 0.030 |
Why?
| | Massachusetts | 1 | 2017 | 174 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2005 | 2007 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5212 | 0.030 |
Why?
| | Blood Cell Count | 1 | 2016 | 54 | 0.030 |
Why?
| | China | 1 | 2017 | 220 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2016 | 92 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1826 | 0.030 |
Why?
| | Hematocrit | 1 | 2016 | 104 | 0.030 |
Why?
| | DNA | 1 | 2023 | 1444 | 0.030 |
Why?
| | Stearic Acids | 1 | 2015 | 16 | 0.030 |
Why?
| | Sarcoglycans | 1 | 2015 | 5 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2016 | 310 | 0.030 |
Why?
| | Lung Volume Measurements | 1 | 2015 | 46 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2016 | 134 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1498 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2015 | 71 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 448 | 0.030 |
Why?
| | Bias | 1 | 2016 | 229 | 0.030 |
Why?
| | HTLV-I Infections | 1 | 1995 | 28 | 0.030 |
Why?
| | Vascular Calcification | 1 | 2016 | 111 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2015 | 33 | 0.030 |
Why?
| | Social Class | 1 | 2017 | 268 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.030 |
Why?
| | Nutritional Status | 1 | 2017 | 362 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2017 | 338 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2016 | 316 | 0.030 |
Why?
| | Leukotriene B4 | 1 | 2014 | 42 | 0.030 |
Why?
| | Potassium Channels | 1 | 2015 | 149 | 0.030 |
Why?
| | Pneumothorax | 1 | 2014 | 50 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 77 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2019 | 876 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 542 | 0.030 |
Why?
| | Host-Parasite Interactions | 1 | 2015 | 118 | 0.030 |
Why?
| | Myosin Heavy Chains | 1 | 2015 | 180 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2064 | 0.030 |
Why?
| | Smoking Cessation | 1 | 2018 | 440 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 361 | 0.030 |
Why?
| | Diet, Western | 1 | 2014 | 82 | 0.030 |
Why?
| | alpha 1-Antitrypsin | 1 | 2014 | 104 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2022 | 1133 | 0.030 |
Why?
| | Health Policy | 1 | 2017 | 405 | 0.030 |
Why?
| | Deferoxamine | 1 | 1993 | 26 | 0.030 |
Why?
| | Jamaica | 1 | 2013 | 5 | 0.030 |
Why?
| | Cotinine | 1 | 2013 | 78 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 860 | 0.030 |
Why?
| | District of Columbia | 1 | 2013 | 33 | 0.030 |
Why?
| | Societies, Dental | 1 | 1993 | 2 | 0.020 |
Why?
| | Aluminum | 1 | 1993 | 43 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 184 | 0.020 |
Why?
| | Gene Order | 1 | 2012 | 27 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2525 | 0.020 |
Why?
| | Educational Status | 1 | 2015 | 464 | 0.020 |
Why?
| | New York | 1 | 2013 | 128 | 0.020 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2012 | 19 | 0.020 |
Why?
| | Dynactin Complex | 1 | 2012 | 5 | 0.020 |
Why?
| | Parathyroid Hormone | 1 | 1993 | 111 | 0.020 |
Why?
| | Immunity, Mucosal | 1 | 2013 | 96 | 0.020 |
Why?
| | Organizational Policy | 1 | 1993 | 84 | 0.020 |
Why?
| | Untranslated Regions | 1 | 2012 | 3 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2009 | 5974 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 910 | 0.020 |
Why?
| | Statistics, Nonparametric | 2 | 2005 | 434 | 0.020 |
Why?
| | Wales | 1 | 2011 | 25 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2011 | 42 | 0.020 |
Why?
| | Adolescent Development | 1 | 2012 | 90 | 0.020 |
Why?
| | England | 1 | 2011 | 108 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2011 | 96 | 0.020 |
Why?
| | Eicosapentaenoic Acid | 1 | 2011 | 38 | 0.020 |
Why?
| | X Chromosome Inactivation | 1 | 2011 | 25 | 0.020 |
Why?
| | Luciferases | 1 | 2011 | 150 | 0.020 |
Why?
| | Microsatellite Repeats | 2 | 2003 | 159 | 0.020 |
Why?
| | Canada | 1 | 2012 | 429 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2014 | 519 | 0.020 |
Why?
| | Biological Evolution | 1 | 2015 | 493 | 0.020 |
Why?
| | Costa Rica | 1 | 2010 | 18 | 0.020 |
Why?
| | Pulmonary Fibrosis | 1 | 2014 | 399 | 0.020 |
Why?
| | Iron | 1 | 1993 | 324 | 0.020 |
Why?
| | Overweight | 1 | 2015 | 588 | 0.020 |
Why?
| | Artifacts | 1 | 2011 | 133 | 0.020 |
Why?
| | Salmeterol Xinafoate | 1 | 2010 | 22 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2015 | 748 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1820 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 397 | 0.020 |
Why?
| | Codon, Nonsense | 1 | 2010 | 43 | 0.020 |
Why?
| | Sex Distribution | 1 | 2011 | 381 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2011 | 134 | 0.020 |
Why?
| | Bone and Bones | 1 | 1993 | 317 | 0.020 |
Why?
| | Introns | 1 | 2011 | 254 | 0.020 |
Why?
| | Albuterol | 1 | 2010 | 75 | 0.020 |
Why?
| | Markov Chains | 1 | 2010 | 126 | 0.020 |
Why?
| | Urban Population | 1 | 2012 | 485 | 0.020 |
Why?
| | Kainic Acid | 1 | 2009 | 34 | 0.020 |
Why?
| | Waist Circumference | 1 | 2010 | 134 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1321 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2010 | 245 | 0.020 |
Why?
| | Biopsy | 1 | 1993 | 1083 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 365 | 0.020 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2009 | 41 | 0.020 |
Why?
| | Acute Disease | 1 | 2012 | 1010 | 0.020 |
Why?
| | Nicotine | 1 | 2012 | 350 | 0.020 |
Why?
| | DNA Replication | 1 | 2011 | 240 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2009 | 166 | 0.020 |
Why?
| | Bronchodilator Agents | 1 | 2010 | 196 | 0.020 |
Why?
| | Mice, Knockout | 2 | 2009 | 3071 | 0.020 |
Why?
| | Disease | 1 | 2009 | 102 | 0.020 |
Why?
| | Hospitals | 1 | 1993 | 696 | 0.020 |
Why?
| | Korea | 1 | 2007 | 17 | 0.020 |
Why?
| | Spirometry | 1 | 2009 | 260 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2012 | 1977 | 0.020 |
Why?
| | beta-Thromboglobulin | 1 | 2007 | 3 | 0.020 |
Why?
| | Quality of Life | 1 | 2019 | 3014 | 0.020 |
Why?
| | Binding Sites | 1 | 2010 | 1316 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2010 | 505 | 0.020 |
Why?
| | Drug Resistance | 1 | 2007 | 150 | 0.020 |
Why?
| | Transcription Factors | 1 | 2014 | 1712 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2009 | 584 | 0.020 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2006 | 32 | 0.020 |
Why?
| | Genetic Testing | 2 | 1999 | 463 | 0.010 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2005 | 42 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 125 | 0.010 |
Why?
| | Hepatitis A Antibodies | 1 | 2005 | 3 | 0.010 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2005 | 42 | 0.010 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2005 | 30 | 0.010 |
Why?
| | Hepatitis A | 1 | 2005 | 26 | 0.010 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 2004 | 25 | 0.010 |
Why?
| | Receptors, Virus | 1 | 2005 | 96 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 2005 | 168 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1739 | 0.010 |
Why?
| | Antigens, Dermatophagoides | 1 | 2004 | 10 | 0.010 |
Why?
| | U937 Cells | 1 | 2004 | 26 | 0.010 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2004 | 16 | 0.010 |
Why?
| | NIH 3T3 Cells | 1 | 2004 | 149 | 0.010 |
Why?
| | Gene Deletion | 1 | 2006 | 389 | 0.010 |
Why?
| | Receptor, Anaphylatoxin C5a | 1 | 2004 | 29 | 0.010 |
Why?
| | Germany | 1 | 2004 | 132 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2004 | 149 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11181 | 0.010 |
Why?
| | Hyperglycemia | 1 | 2007 | 365 | 0.010 |
Why?
| | Aquaporins | 1 | 2001 | 8 | 0.010 |
Why?
| | Osmosis | 1 | 2001 | 17 | 0.010 |
Why?
| | Chimera | 1 | 2001 | 61 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2001 | 133 | 0.010 |
Why?
| | Optics and Photonics | 1 | 2001 | 42 | 0.010 |
Why?
| | Permeability | 1 | 2001 | 166 | 0.010 |
Why?
| | Western Australia | 1 | 2001 | 9 | 0.010 |
Why?
| | Lasers | 1 | 2001 | 130 | 0.010 |
Why?
| | HIV-2 | 1 | 2000 | 18 | 0.010 |
Why?
| | Cost Control | 1 | 2000 | 37 | 0.010 |
Why?
| | Herpesvirus 6, Human | 1 | 2000 | 14 | 0.010 |
Why?
| | Toxoplasma | 1 | 2000 | 45 | 0.010 |
Why?
| | Cytomegalovirus | 1 | 2000 | 163 | 0.010 |
Why?
| | Herpesvirus 4, Human | 1 | 2000 | 165 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2929 | 0.010 |
Why?
| | Expert Testimony | 1 | 1999 | 44 | 0.010 |
Why?
| | Immunoglobulin M | 1 | 2000 | 287 | 0.010 |
Why?
| | Observer Variation | 1 | 1999 | 357 | 0.010 |
Why?
| | Water | 1 | 2001 | 466 | 0.010 |
Why?
| | Lymphocytes | 1 | 2000 | 398 | 0.010 |
Why?
| | Rubella virus | 1 | 1997 | 9 | 0.010 |
Why?
| | Paresthesia | 1 | 1997 | 14 | 0.010 |
Why?
| | Arthralgia | 1 | 1997 | 57 | 0.010 |
Why?
| | Vaccines, Attenuated | 1 | 1997 | 130 | 0.010 |
Why?
| | Muscular Diseases | 1 | 1997 | 113 | 0.010 |
Why?
| | Arthritis | 1 | 1997 | 104 | 0.010 |
Why?
| | HIV-1 | 1 | 2000 | 895 | 0.010 |
Why?
| | Postpartum Period | 1 | 1997 | 354 | 0.010 |
Why?
| | Pain | 1 | 1997 | 781 | 0.010 |
Why?
| | Physicians | 1 | 1999 | 942 | 0.010 |
Why?
| | Vaccination | 1 | 1997 | 1472 | 0.000 |
Why?
|
|
Mathias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|